跳至主要内容
临床试验/ACTRN12616001174471
ACTRN12616001174471已完成未知

Efficacy of nasogastric and endotracheal tube securement devices, preventative dressings and topical skin applications for reducing device-related pressure injuries in intensive care patients; a pilot study

Queensland University of Technology0 个研究点目标入组 100 人开始时间: 2016年8月26日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • All ICU patients = or >18 years who have a NGT and/or ETT in situ
  • Patients who are expected to remain in ICU > 24 hours
  • NGT or ETT inserted a maximum of 12 hours prior to ICU admission
  • Patients readmitted to ICU with no oral or nasal skin injury present
  • NGT arm only - must have wide bore NGT and an ETT in situ.

排除标准

  • Burn patients with an ETT wired in place (ETT arm only)
  • Patients with NGT sutured in place or nasal bridle (NGT arm only)
  • Patients with facial trauma
  • Traumatic brain injured patients requiring intracranial pressure monitoring and/or ventricular drainage of cerebrospinal fluid
  • Cervical spine injured patients who have a hard collar in situ
  • Hirsute patients with beards where patient permission to shave is not possible
  • Patients who are receiving non-invasive ventilation
  • Patients with a device (NGT or ETT) predicted to be in situ < 48 hours.
  • Patients with a community or hospital-acquired NGT or ETT PI diagnosed within 24 hours of admission to the ICU.
  • Patients on whom treatment is withdrawn or who are being palliated.
  • Patients currently enrolled on three studies in the ICU.

研究者

相似试验

Efficacy of nasogastric and endotracheal tube... | 临床试验